
AI Spots Brain Tumor Risks From Routine Slides
High-tech cancer diagnostics are currently a luxury of the wealthiest health systems, but a shift in how we analyze basic tissue slides could soon level the playing field.
Discover the newest research about AI innovations in ๐งช Pathology.

High-tech cancer diagnostics are currently a luxury of the wealthiest health systems, but a shift in how we analyze basic tissue slides could soon level the playing field.

Hiring a commercial AI to read breast cancer biopsies does not just introduce errors; it forces clinicians to choose which specific flavor of diagnostic failure they can tolerate.

A new AI tool reveals that many prostate cancers upgraded during active surveillance were actually mischaracterized from the very start.

A new study shows that small, locally hosted AI models can clean up messy clinical text better than expected, without risking patient privacy.

A new deep-learning model diagnoses autoimmune hepatitis with expert-level accuracy in some scenarios, but its failure against hepatitis B reveals a critical diagnostic blind spot.

A new computational pathology model exposes the limits of human sight in oncology, diagnosing complex brain tumors in minutes rather than weeks.

Regulators just crossed a digital rubicon by accepting AI-generated pathology data to evaluate metabolic liver disease treatments.

AI models outperform physicians in summarizing complex cancer pathology reports, according to a recent study. ๐๐ฉบ

Philips expands digital pathology with cloud-enabled IntelliSite, enhancing diagnostics and productivity in healthcare organizations. ๐ฅ๐ป

Deep learning in radiation oncology: promising AI for pelvic malignancies. ๐๐ค Systematic review protocol registered on PROSPERO. ๐